These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2113853)
1. [Stimulation of vascular prostacyclin formation. A new action principle for decreasing blood pressure?]. Simmet T; Peskar BA Dtsch Med Wochenschr; 1990 Jun; 115(25):994-6. PubMed ID: 2113853 [No Abstract] [Full Text] [Related]
2. Enhancement of prostacyclin generation by cicletanine (an in vivo investigation). Bourgain RH; Deby C Drugs Exp Clin Res; 1988; 14(2-3):135-9. PubMed ID: 3138096 [TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of action of the antihypertensive agent cicletanine. Castro A; Parra L; Fuentes JA Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():51-4. PubMed ID: 2514669 [TBL] [Abstract][Full Text] [Related]
4. [Increase of the prostacyclin/thromboxane A2 ratio in the plasma of rabbits treated with cicletanine, a new antihypertensive agent]. Deby C; Deby-Dupont G; Braquet P; Bourgain R; Pincemail J; Bosquet D Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():97-9. PubMed ID: 3142438 [TBL] [Abstract][Full Text] [Related]
5. [Effect of cicletanine on prostacyclin generation in vivo]. Bourgain RH; Deby C; Andries R Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():33-6. PubMed ID: 2514665 [TBL] [Abstract][Full Text] [Related]
6. Prostacyclin and hypertension. Pace-Asciak CR Mater Med Pol; 1980; 12(3):181-6. PubMed ID: 7019589 [No Abstract] [Full Text] [Related]
7. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension. Bouthier JA; Safar ME; Deschamps E; Tarrade T Drugs Exp Clin Res; 1988; 14(2-3):221-4. PubMed ID: 3416724 [TBL] [Abstract][Full Text] [Related]
8. [Cicletanine avoids the proliferation of vascular smooth muscle in the spontaneously hypertensive rat]. Bukoski RD Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1313-6. PubMed ID: 2124474 [TBL] [Abstract][Full Text] [Related]
9. How do thiazide and thiazide-like diuretics lower blood pressure? Hughes AD J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):155-60. PubMed ID: 15803433 [TBL] [Abstract][Full Text] [Related]
10. Rhomotoxin pharmacologic action in lowering blood pressure and slowing heart rate. Mao HY; Li CY; Cui JJ; Feng YB; Hu WS; Guo QG; Jiang MX Chin Med J (Engl); 1982 May; 95(5):311-8. PubMed ID: 6814841 [No Abstract] [Full Text] [Related]
11. [Influence of tetrandrine on the left ventricular function and peripheral blood vessels in canines]. Zeng FD; Fang DC; Leng DM; Lü FH Yao Xue Xue Bao; 1982 Aug; 17(8):561-5. PubMed ID: 7180489 [No Abstract] [Full Text] [Related]
13. General pharmacology of cicletanine. Clostre F; Etienne A Drugs Exp Clin Res; 1988; 14(2-3):73-82. PubMed ID: 3416726 [TBL] [Abstract][Full Text] [Related]
14. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models. Malherbe E; Le Hegarat M; Clostre F; Braquet P Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955 [TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142 [TBL] [Abstract][Full Text] [Related]
16. [The dependence of the hemodynamic shifts in the systemic arterial and venous vascular beds on the degree of change in the arterial pressure under the action of vasoactive substances]. Lioznov MV; Samoĭlenko AV; Iurov AIu Fiziol Zh SSSR Im I M Sechenova; 1990 Mar; 76(3):362-70. PubMed ID: 2164970 [TBL] [Abstract][Full Text] [Related]
17. [Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine]. Hornych A; Boisson J; Gaschard JC Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():85-90. PubMed ID: 2514674 [TBL] [Abstract][Full Text] [Related]
18. Is a K+-prostacyclin interaction involved in the mechanism of action of some diuretic drugs? Braquet P; Deby C; Garay R; Larrue J; Bourgain R Lancet; 1983 May; 1(8335):1218-9. PubMed ID: 6134011 [No Abstract] [Full Text] [Related]
19. [Blood pressure-lowering effect of Baycaron]. Fink H Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):205-12. PubMed ID: 4902016 [No Abstract] [Full Text] [Related]
20. Properties of catapres, a new hypotensive drug: a preliminary report. Ng J; McGrgor DD; Taylor KM; Smirk H N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015 [No Abstract] [Full Text] [Related] [Next] [New Search]